Description
Retatrutide 20 mg – Triple Receptor Agonist Research Peptide
Retatrutide 20 mg is a high-purity lyophilized research peptide supplied in a sterile pen containing 20 mg of active compound per pen. This investigational molecule is classified as a next-generation triple receptor agonist targeting GLP-1, GIP, and glucagon receptors.
Retatrutide is currently studied in metabolic and endocrinology research due to its multi-pathway receptor activity and coordinated signaling profile. The compound is intended strictly for laboratory and scientific research use only.
Mechanism of Action
Retatrutide is designed to simultaneously activate three key metabolic receptors:
• GLP-1 (Glucagon-Like Peptide-1) receptors
• GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors
• Glucagon receptors
This triple-agonist activity is being investigated in laboratory settings for its role in metabolic regulation and hormonal signaling pathways.
Research Applications
Retatrutide has become an important compound in advanced metabolic research. Scientific investigations focus on its potential involvement in:
• Metabolic regulation models
• Energy balance research
• Body weight signaling pathways
• Glucose metabolism studies
• Adipose tissue signaling
• Hormonal interaction mechanisms
• Insulin sensitivity research
• Obesity-related metabolic pathway analysis
The multi-receptor profile differentiates Retatrutide from single-pathway peptides and has led to increased interest in comparative receptor studies.
Product Specifications
Product Name: Retatrutide
Content: 20 mg per pen (3 ml)
Form: Aqueous solution
Grade: Research use only
Purity: High laboratory-grade purity
Packaging: Sterile pen
Storage: Store refrigerated at 2–8°C
Stability and Handling
The aqueous solution form ensures stability when stored properly under refrigerated conditions.
Recommended laboratory handling:
• Store at 2–8°C
• Protect from light and moisture
• Avoid repeated freeze–thaw cycles
• Reconstitute under sterile laboratory conditions
Proper handling preserves peptide integrity and experimental reliability.
Research Classification
Retatrutide is an investigational peptide compound intended exclusively for:
• In vitro laboratory research
• Analytical testing
• Scientific experimentation
• Controlled research applications
This product is not approved for medical, therapeutic, veterinary, or diagnostic use.
Important Notice
This product is sold strictly for laboratory research purposes only.
It is not intended for human consumption, medical use, or clinical application. By purchasing this product, the buyer confirms that it will be used solely for lawful scientific research.
